About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Specimens for Septin 9 Performance

NCT01329718·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Epigenomics, Inc

Age

50–any

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

50 years of age or older at the time of the blood draw
Histologically confirmed or strong clinical suspicion of adenocarcinoma of the colon or rectum
CRC defined as invasive adenocarcinoma

You may not be if

Previous personal history of colorectal cancer
Any cancer specific treatment (e.g. polypectomy, chemotherapy, radiation, or surgery) prior to blood draw, including neoadjuvant treatment
Known infection with HIV, HBV or HCV
Subject concurrently receiving intravenous fluid at the time of the specimen collection

The record

StatusCompleted

PhaseEarly phase 1

Taking part562

StartedMay 2011

UpdatedAug 4, 2014

Conditions

Colorectal Cancer

Clareo Health | Specimens for Septin 9 Performance